Evidence map›Paper›PMID 31106400›Full record

ArticleBiometrics2019

Semiparametric frailty models for zero-inflated event count data in the presence of informative dropout.

Guoqing Diao, Donglin Zeng, Kuolung Hu, Joseph G Ibrahim

Registry-linked trialAbstract read
In one paragraph

Article in Biometrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00614523 (A Randomized, Double Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00614523 phase2completednot on this map

A Randomized, Double Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

TypeinterventionalSponsorAmgenRan2008 to 2015Enrolled250ConditionsMDS, Myelodysplastic Syndromes, ThrombocytopeniaArmsPlacebo, Romiplostim
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Guoqing DiaoDepartment of Statistics, George Mason University, Fairfax, VA.ORCID 0000-0001-7304-9591
Donglin ZengDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.ORCID 0000-0003-0843-9280
Kuolung HuAmgen Inc, Thousand Oaks, CA.
Joseph G IbrahimDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.

Funding

Bayesian Approaches to Model Selection for Survival DataR01GM070335 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI IBRAHIM, JOSEPH G · 2003 to 2019
$4.0M
NIGMS NIH HHS R01 GM070335
6 · The paper itself

Abstract

Recurrent events data are commonly encountered in medical studies. In many applications, only the number of events during the follow-up period rather than the recurrent event times is available. Two important challenges arise in such studies: (a) a substantial portion of subjects may not experience the event, and (b) we may not observe the event count for the entire study period due to informative dropout. To address the first challenge, we assume that underlying population consists of two subpopulations: a subpopulation nonsusceptible to the event of interest and a subpopulation susceptible to the event of interest. In the susceptible subpopulation, the event count is assumed to follow a Poisson distribution given the follow-up time and the subject-specific characteristics. We then introduce a frailty to account for informative dropout. The proposed semiparametric frailty models consist of three submodels: (a) a logistic regression model for the probability such that a subject belongs to the nonsusceptible subpopulation; (b) a nonhomogeneous Poisson process model with an unspecified baseline rate function; and (c) a Cox model for the informative dropout time. We develop likelihood-based estimation and inference procedures. The maximum likelihood estimators are shown to be consistent. Additionally, the proposed estimators of the finite-dimensional parameters are asymptotically normal and the covariance matrix attains the semiparametric efficiency bound. Simulation studies demonstrate that the proposed methodologies perform well in practical situations. We apply the proposed methods to a clinical trial on patients with myelodysplastic syndromes.

Indexed as

Likelihood FunctionsModels, StatisticalPoisson DistributionBiometryComputer SimulationFollow-Up StudiesHumansMyelodysplastic SyndromesProportional Hazards ModelsRecurrenceCox modelinformative dropoutnonhomogeneous Poisson processnonparametric maximum likelihood estimatorssemiparametric efficiencyzero-inflated Poisson model

Identifiers

PMID31106400
PMCPMC7573886

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.